With over 40 years of experience in clinical research and development, Graham Belgrave brings deep strategic and operational insight gained from senior leadership and executive roles within major pharmaceutical organisations including Pfizer, GlaxoSmithKline, Roche, Takeda, and Grunenthal. His experience working across both the sponsor and vendor sides of study delivery enables him to anticipate challenges, optimise outsourcing strategies, and build partnerships that deliver measurable results. Graham works closely with clients to de risk complex development programmes, accelerate execution, and maximise strategic value across European and global clinical portfolios. He is an active member and honorary fellow of the Institute of Clinical Research U.K. (ICR), a fellow of the Royal Society of Medicine, a chartered scientist and a member of the Institute of Biomedical Science, an assessor for the U.K. Science Council and a companion of the Chartered Management Institute.